Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07764237
A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy AdultsModernaTX, Inc.Not Yet RecruitingPhase 1
NCT07764237Not Yet Recruiting
Phase 1
A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (...ModernaTX, Inc.
NCT07762105
Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye DiseaseBanu Aji DibyasaktiNot Yet RecruitingPhase 1
NCT07762105Not Yet Recruiting
Phase 1
Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Pa...Banu Aji Dibyasakti
NCT07761936
Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor FluctuationsUniversita di VeronaRecruitingPhase 3
NCT07761936Recruiting
Phase 3
Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fl...Universita di Verona
NCT07763080
Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase Inhibitors Therapy After MastectomyCairo UniversityNot Yet RecruitingNot Applicable
NCT07763080Not Yet Recruiting
Not Applicable
Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase...Cairo University
NCT07762053
Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomonitor TonometerEyeCBetter CorporationNot Yet RecruitingNot Applicable
NCT07762053Not Yet Recruiting
Not Applicable
Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomon...EyeCBetter Corporation
NCT07763769
Validation of the MedHub AutocathFFR Software Device for Non-Invasive Fractional Flow Reserve (FFR)Medhub Ltd.Completed
NCT07763769Completed
—
Validation of the MedHub AutocathFFR Software Device for Non-Invasive Fractional...Medhub Ltd.
NCT07763145
Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resistive Index in Neonatal Hypoxic Ischemic Encephalopathy: A Randomized Control TrialHayatabad Medical ComplexNot Yet RecruitingNot Applicable
NCT07763145Not Yet Recruiting
Not Applicable
Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resisti...Hayatabad Medical Complex
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07763249
Comparison of Paravertebral Versus Epidural Block for Post-thoracotomy Pain ControlHospital de Clinicas de Porto AlegreNot Yet RecruitingNot Applicable
NCT07763249Not Yet Recruiting
Not Applicable
Comparison of Paravertebral Versus Epidural Block for Post-thoracotomy Pain Cont...Hospital de Clinicas de P...
NCT07763782
Dose-Response Structured Calf Muscle Pump Activation Strategies Versus Unsupervised Home WalksMTI UniversityNot Yet RecruitingNot Applicable
NCT07763782Not Yet Recruiting
Not Applicable
Dose-Response Structured Calf Muscle Pump Activation Strategies Versus Unsupervi...MTI University
NCT07763405
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic StrokeThe First Affiliated Hospital of Nanchang UniversityNot Yet RecruitingPhase 4
NCT07763405Not Yet Recruiting
Phase 4
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic StrokeThe First Affiliated Hosp...
NCT07763860
Therapeutic Effects of Music on Procedural OutcomesBahaa Bou DarghamRecruitingNot Applicable
NCT07763860Recruiting
Not Applicable
Therapeutic Effects of Music on Procedural OutcomesBahaa Bou Dargham
NCT07762066
Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual MenFenway Community HealthRecruitingNot Applicable
NCT07762066Recruiting
Not Applicable
Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression A...Fenway Community Health
NCT07762274
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke and Brain Injury, Further Validation of RehAtt® DiSTRO Assessment of Cognitive and Visual FunctionDepartment of clinical sciences at Danderyd hospitalCompleted
NCT07762274Completed
—
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke an...Department of clinical sc...
NCT07762950
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic PancreatitisChanghai HospitalNot Yet Recruiting
NCT07762950Not Yet Recruiting
—
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancre...Changhai Hospital
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07763574
Effects of Strength Training Combined With Sustainable Source of Omega-3 Fatty Acids on Muscle Strength and Cognitive Functions in Adults Controlled TrialGdansk University of Physical Education and SportEnrolling By InvitationNot Applicable
NCT07763574Enrolling By Invitation
Not Applicable
Effects of Strength Training Combined With Sustainable Source of Omega-3 Fatty A...Gdansk University of Phys...
NCT07762001
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MDActive Not RecruitingPhase 1
NCT07762001Active Not Recruiting
Phase 1
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MD
NCT07763171
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal AdenocarcinomaGruppo Oncologico del Nord-OvestNot Yet RecruitingPhase 3
NCT07763171Not Yet Recruiting
Phase 3
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-neg...Gruppo Oncologico del Nor...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting4 (20%)
Completed2 (10%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 13 (15%)
Phase 32 (10%)
Phase 41 (5%)
Phase 21 (5%)